Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting earnings this Thursday after market close. Here’s what to look for.
Feb 18 (Reuters) - Insulet reported better-than-expected fourth-quarter results on Wednesday, on the back of strong demand for its tubeless insulin pumps that eliminate the need for daily injections.
St. John Neumann's Buckley, diagnosed with Type 1 diabetes at 8, navigates the daily challenges of managing his condition ...
Insulet stock is up on fourth-quarter results ahead of consensus, with company leaders talking about talent, technology, and ...
Insulet (NASDAQ:PODD) closed out 2025 with what management described as another “strong quarter,” extending a streak of 10 ...
Q4 2025 Management View Ashley McEvoy, CEO, reported "we closed 2025 with another strong quarter, recording our 10th consecutive year of 20% or greater constant currency revenue growth," citing ...
Explore the top construction companies in San Diego driving major projects in healthcare, aerospace, and more.